| Objective To investigate the DKK1and sclerostin expression and clinical significanein patients with ankylosing spondylitis in peripheral blood.Methods The study was performed in40patients with AS,34males and6females,age range17~45yrs, mean age28±8yrs which met the AS New York revisedclassification criteria in1984.20healthy controls, include17males3females,meanage27±2yrs. ex-and age-matched, served as a control group. All subjects receivedinformed consent in this study. AS patients was divided into untreated group(withoutregular treating more than three months,n=16) and treated group(non-steroidalanti-inflammatory and DMARDS more than three months,n=12) and biological agentsgroup(receiving at least one biological agent more than two months,n=12).Diseaseactivity was assessed with BASDAI,ESR,CRP,Ig,clinical data and sacroiliac jointimaging were collected.Imaging of the sacroiliac joint classification was defined as:Ilevel was suspicious;IIlevel may have limited erosion,sclerosis,but joint space wasnormal; IIIlevel has obvious abnormal change including erosion,sclerosis,joint spacenarrow even joint ankylosis.IVlevel have serious joint ankylosis.we difined sacroiliacjoint classification level<2as early period,>2as later period. All sample was collectedin room temperature then centrifugal at3000r/min for20min.Serum samples weretaken from each subject and stored at–70C until the assays were per-formed. thelevel of DKK1and sclerostin in sera were measured by enzyme-linked immunosorbentassay according to the introduction. Result①The level of DKK1in AS serum was significantly higher than that in thehealthy control group(P<0.05);②The level of DKK1in using anti-TNF-α group islower than that in the untreated group (P<0.05);③DKK1and BASDAI scorespositively correlated(,r=0.337, P<0.05),there was no correlation between DKK1andscleroston with ESR,CRP,IgG,IgA,IgM.;④The levels of sclerostin in the serum of ASpatients was higher than that in normal control group (P<0.01);⑤The sclerostinlevels of early AS patients was higher than that of the later AS patients (P<0.05)Conclusion DKK1may be involved in inflammatory process of AS patients,inhibition of TNF-α can affect the expression of DKK1, sclerostin levels werediferences in the early and later period AS patients. Objective To investigate the pathophysiology of AS-related osteoporosis byinvestigating the relation between bone mineral density(BMD) and bone turnovermarkers.Methods forty-seven AS patients were included in this study.including36males and11female.age range16~48yrs, mean age32±9yrs.disease duration rang1month to20years,mean81±69months which met the AS New York revised classificationcriteria in1984.25ex-and age-matched, served as a healthy controls,group. Allsubjects received informed consent in this study. AS patients was divided into untreatedgroup(without regular treating more than three months) and treated group(non-steroidalanti-inflammatory and DMARDS more than three months) and biological agentsgroup(receiving at least one biological agent more than two months).we difinedsacroiliac joint classification level<2as early period,>2as later period. BMD of lumbarspine(L1-L4), fermoral neck and radius were using dual-energy X-ray absorptionmethod.According to the World Health Organiziation(WHO) classification,osteopeniawas defined as a Z-score between-1and-2.5and osteoporo as a Z-score< -2.5.BASDAI,ESR,Ig was collected.bone formation markers including procollagen type1N-terminal peptide(PINP) and osteocalcin (OC),the formal was measured byradioimmunoassay and the later was measured by immunoradiometric assay and boneresorption marker β-CrossLaps was measured by electrochemiluminescenceimmunoassay.Results①47%of AS patients has bone loss(osteopenia was30%,osteoporosis was17%) while the percentage in the healthy control group is20%(osteopenia was20%,osteoporosis was0%). BMD of lumbar spine, fermoral neck and radius were lowerthan the control (p<0.05).②BMD of lumbar spine in later period group was was higerthan the early group,however,the BMD in femoral neck was not.③The PINP,OC andβ-CrossLaps has no significant difference in different periods.(p>0.05).④BMD oflumbar spine was negatively correlated with the β-CrossLaps and ESR, The BMD infermoral neck was negatively correlated with β-CrossLaps and OC,but they were notcorrelaed with disease duration and BADSAI.⑤BMD of lumbar spine and fermoralneck were increased in receiving anti-TNF-α group than untreated group(p<0.05)Conclusion Osteoporosis is gerenal in AS.,bone turnover including boneformation and bone resorption were increased in AS. β-CrossLaps is likely to precictbone loss in AS.anti-TNF-α therapy can increase BMD. |